Literature DB >> 32540756

Photothermal conversion-coordinated Fenton-like and photocatalytic reactions of Cu2-xSe-Au Janus nanoparticles for tri-combination antitumor therapy.

Yuanlin Wang1, Zhenglin Li1, Ying Hu2, Jing Liu3, Mengyu Guo3, Hengxiang Wei1, Shanliang Zheng2, Tingting Jiang1, Xiang Sun1, Zhuo Ma2, Ye Sun4, Flemming Besenbacher5, Chunying Chen3, Miao Yu6.   

Abstract

In vivo chemical reactions activated by the tumor microenvironment (TME) are particularly promising for antitumor treatments. Herein, employing Cu2-xSe-Au Janus nanoparticles (NPs), photothermal conversion-coordinated Fenton-like and photocatalytic reactions are demonstrated in vitro/vivo. The amorphous form of Cu2-xSe and the catalytic effect of Au benefit the OH generation, and the photo-induced electron‒hole separation of the Janus NPs produces additional OH. The plasmonic electrons of Au facilitate the conversion from Cu2+ to Cu+. Both Cu2-xSe and Au contributes to the efficient photothermal conversion, further promoting the reactions. As a result, the H2O2 utilization rate is largely increased, and remarkable generation of reactive oxygen species is achieved by cell endogenous H2O2in vitro/vivo. A competent tumor inhibition effect is afforded, with high-contrast multimodal imaging. This work opens up the route synergistically integrating photothermal therapy with chemodynamic therapy and photocatalytic therapy into tri-combination antitumor therapy, simply by heterojunction of semiconductor and noble metal.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemodynamic therapy; In vivo chemical Reaction; Multimodal imaging; Photocatalytic therapy; Photothermal therapy

Mesh:

Substances:

Year:  2020        PMID: 32540756     DOI: 10.1016/j.biomaterials.2020.120167

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

Review 1.  Fenton metal nanomedicines for imaging-guided combinatorial chemodynamic therapy against cancer.

Authors:  Peng Liu; Ying Peng; Jinsong Ding; Wenhu Zhou
Journal:  Asian J Pharm Sci       Date:  2021-10-31       Impact factor: 9.273

2.  Extracellular-vesicles delivered tumor-specific sequential nanocatalysts can be used for MRI-informed nanocatalytic Therapy of hepatocellular carcinoma.

Authors:  Han Wu; Hao Xing; Meng-Chao Wu; Feng Shen; Yu Chen; Tian Yang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

3.  Bayesian Particle Instance Segmentation for Electron Microscopy Image Quantification.

Authors:  Batuhan Yildirim; Jacqueline M Cole
Journal:  J Chem Inf Model       Date:  2021-03-08       Impact factor: 4.956

Review 4.  Metal peroxides for cancer treatment.

Authors:  Jin He; Lian-Hua Fu; Chao Qi; Jing Lin; Peng Huang
Journal:  Bioact Mater       Date:  2021-02-13

Review 5.  Nanozymes-recent development and biomedical applications.

Authors:  Xiangyi Ren; Dongxu Chen; Yan Wang; Huifang Li; Yabing Zhang; Hongying Chen; Xi Li; Minfeng Huo
Journal:  J Nanobiotechnology       Date:  2022-02-22       Impact factor: 10.435

Review 6.  Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment.

Authors:  Yandong Wang; Fucheng Gao; Xiaofeng Li; Guiming Niu; Yufei Yang; Hui Li; Yanyan Jiang
Journal:  J Nanobiotechnology       Date:  2022-02-05       Impact factor: 10.435

7.  Electron Transfer Strategies to Regulate Carriers' Separation for Intensive Pyroelectric Dynamic Therapy With Simultaneous Photothermal Therapy.

Authors:  Bingxia Sun; Yun Meng; Tianlin Song; Jieyun Shi; Xinhong He; Peiran Zhao
Journal:  Front Chem       Date:  2022-04-12       Impact factor: 5.545

8.  Rationally designed dual-plasmonic gold nanorod@cuprous selenide hybrid heterostructures by regioselective overgrowth for in vivo photothermal tumor ablation in the second near-infrared biowindow.

Authors:  Beibei Shan; Haitao Wang; Linhu Li; Guangzhi Zhou; Yu Wen; Mingyang Chen; Ming Li
Journal:  Theranostics       Date:  2020-09-19       Impact factor: 11.556

Review 9.  Chemodynamic nanomaterials for cancer theranostics.

Authors:  Jingqi Xin; Caiting Deng; Omer Aras; Mengjiao Zhou; Chunsheng Wu; Feifei An
Journal:  J Nanobiotechnology       Date:  2021-06-28       Impact factor: 10.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.